GlobeNewswire by notified

Evli Plc: Managers' Transactions

Share

EVLI PLC MANAGERS' TRANSACTIONS February 27, 2023 AT 12:15 PM (EET/EEST)

____________________________________________
Person subject to the notification requirement
Name: Teuvo Salminen
Position: Member of the Board/Deputy member
Issuer: Evli Oyj
LEI: 984500F4CCF3AD74F766
Notification type: INITIAL NOTIFICATION
Reference number: 26092/5/4

____________________________________________
Transaction date: 2023-02-24
Venue: NASDAQ HELSINKI LTD (XHEL)
Instrument type: SHARE
ISIN: FI4000513437
Nature of transaction: DISPOSAL

Transaction details
(1): Volume: 20000 Unit price: 19.35 EUR

Aggregated transactions (1):
Volume: 20000 Volume weighted average price: 19.35 EUR


EVLI PLC


Additional information:

Mikaela Herrala, Head of Marketing, Communications and IR, Evli Plc, tel. +358 50 544 5740, mikaela.herrala@evli.com


Evli in brief

We see wealth as an engine to drive progress. We draw on our heritage, broad expertise and Nordic values to grow and manage wealth for institutions, corporations and private persons in a responsible way.

We are the leading asset manager in Finland* offering a broad range of services including mutual funds, asset management and capital markets services, alternative investment products, equity research, share plan design and administration as well as Corporate Finance services. Responsible investing is integrated in every investment decision and our expertise is widely acknowledged by our clients. Evli has Finland's best expertise in responsible investment**.

Evli Group employs around 300 professionals and Evli has a total of EUR 16.0 billion in client assets under management (net 12/2022). Evli Plc’s B shares are listed on Nasdaq Helsinki Ltd.

*Kantar Prospera External Asset Management Finland 2015, 2016, 2017, 2018, 2019, 2021, Kantar Prospera Private Banking 2019, 2020 Finland
**SFR Scandinavian Financial Research Institutional Investment Services Finland 2021, 2022

Distribution: Nasdaq Helsinki, main media, www.evli.com


To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Basilea reports presentation of new data for ceftobiprole (Zevtera®) at ESCMID Global 20243.5.2024 07:15:00 CEST | Press release

Allschwil, Switzerland, May 03, 2024 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today that scientific presentations with new data on its antibiotic ceftobiprole (Zevtera®) have been presented at ESCMID Global 2024, the annual meeting of the European Society of Clinical Microbiology and Infectious Diseases, which took place from April 27 to 30, 2024 in Barcelona, Spain. Dr. Marc Engelhardt, Chief Medical Officer of Basilea, stated: “The data presented at ESCMID Global 2024 provide further evidence for the differentiated profile of ceftobiprole in the treatment of severe bacterial bloodstream infections, including those involving methicillin-resistant Staphylococcus aureus, MRSA, and pulmonary infections.” Ceftobiprole was recently approved by the US Food and Drug Administration (FDA), supported by data from three phase 3 studies: ERADICATE

Hexagon Purus ASA: Results for the first quarter 20243.5.2024 07:00:00 CEST | Press release

Selected key developments in Q1 2024: All-time high quarterly revenue of NOK 407 million in the first quarter of 2024, up 67% from the first quarter of 2023;EBITDA of NOK -97 million in the first quarter of 2024. This corresponds to an EBITDA margin of -24%, up from -46% in the first quarter of 2023;Issued convertible bond of approximately NOK 1,000 million following approval by an Extraordinary General Meeting (EGM) on 11 January 2024. Bond issue supported by Mitsui & Co., Ltd., Hy24 and Hexagon Composites;Construction of all new production facilities completed and extensive ramp-up activities across the new manufacturing footprint is ongoing;Segment financial reporting introduced from the first quarter of 2024;Exited the quarter with order backlog consisting of firm purchase orders of approximately NOK 1.2 billion, providing solid line-of-sight to full-year revenue ambitions. “We have just reported a record quarter for Hexagon Purus, keeping us well on track to meet our targets for 2

BTS Group AB (publ) Interim report January – March 20243.5.2024 07:00:00 CEST | Press release

P R E S S R E L E A S E Stockholm, May 3, 2024 Improved growth and margins, despite challenging market January 1 – March 31, 2024 Net sales MSEK 619 (579). Currency adjusted growth +7%.EBITA +23%, MSEK 58 (47).EBITA margin 9.5 (8.2) %.Profit after tax +135%, MSEK 53 (23), excluding the reversed provision of earn-out +11%, MSEK 25 (23).1)Earnings per share +135%, SEK 2.75 (1.17), excluding the reversed provision of earn-out +11%, SEK 1.30 (1.17).1) ”BTS’s growth and profitability improved during the first quarter due to increasing sales volumes and the efficiency measures implemented during 2023.” Jessica Skon, CEO of BTS Group AB Outlook 2024 The 2024 full-year outlook is unchanged; the result (EBITA) is expected to be better than in 2023. For more information, please contact: Michael Wallin Head of investor relations BTS Group AB (publ) michael.wallin@bts.com +46-58 70 70 02 +46-708-78 80 19 This information is information that BTS Group AB is obliged to make public pursuant to the EU

BTS Group AB (publ) Delårsrapport januari – mars 20243.5.2024 07:00:00 CEST | Pressemelding

P R E S S R E L E A S E Stockholm den 3 maj 2024 Ökad tillväxt och marginal trots utmanande marknad 1 januari – 31 mars 2024 Nettoomsättning 619 (579) MSEK. Tillväxt justerad för valutaeffekter +7%.EBITA +23%, 58 (47) MSEK.EBITA-marginal 9,5 (8,2) %.Resultat efter skatt +135%, 53 (23) MSEK, exklusive återförd avsättning för tilläggsköpeskilling +11%, 25 (23) MSEK.1)Resultat per aktie +135%, 2,75 (1,17) SEK, exklusive återförd avsättning för tilläggsköpeskilling +11%, 1,30 (1,17) SEK.1) ”BTS tillväxt och lönsamhet förbättrades under det första kvartalet tack vare ökade försäljningsvolymer och de effektiviseringsåtgärder som genomfördes under 2023.” Jessica Skon, VD för BTS Group AB Utsikter 2024 Helårsutsikten för 2024 är oförändrad; resultatet (EBITA) förväntas bli bättre än föregående år. För mer information, vänligen kontakta: Michael Wallin IR-chef BTS Group AB (publ) michael.wallin@bts.com 08-58 70 70 02 0708-78 80 19 Denna information är sådan information som BTS Group AB (publ) ä

Belships ASA: Amendment of Term Loan Facility3.5.2024 07:00:00 CEST | Press release

Belships has agreed to amend a USD 90m Term Loan Facility for six vessels, which is the only senior secured bank loan in the company today. Four vessels will remain debt free. The Loan Facility has an interest rate of SOFR+195 bps which is 55 bps lower than the previous facility. The loan matures in May 2029 and the first instalment is due in 2025. Furthermore, a new undrawn Accordion Tranche of USD 100m will be available. Lenders for the Loan Facility are DNB Bank, Nordea and Sparebank 1 SR-Bank. For further information, please contact: Lars Christian Skarsgård, Chief Executive Officer, phone +47 977 68 061 or e-mail LCS@belships.no Yngve Aslaksen Gram, Chief Financial Officer, phone +47 454 03 113 or e-mail yngve.gram@belships.no This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act

HiddenA line styled icon from Orion Icon Library.Eye